109°F
weather icon Clear

FDA recalls chocolate, gummies after illness reported in Nevada

Updated July 2, 2024 - 6:56 pm

The U.S. Food & Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have issued a recall for products that led to illnesses in multiple states, including Nevada.

According to a news release, the FDA advises consumers to not eat, sell or serve any flavor of Diamond Shruumz-brand chocolate bars, cones and gummies.

In a news release, the FDA said all flavors of Diamond Shruumz-brand products have been recalled:

  • Microdosing Chocolate Bars.
  • Infused Cones.
  • Micro-Dose and Mega-Dose/Extreme Gummies.

The agency says there have been 39 illnesses reported across 20 states, including Nevada.

“People who became ill after eating Diamond Shruumz-brand products reported a variety of severe symptoms including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting,” the FDA said in the release.

The products can be purchased online and in person at a variety of retail locations nationwide including smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC), according to the agency.

Officials say that if you become ill after consuming these products, you should contact your healthcare provider and/or call the Poison Help Line at 800-222-1222. The FDA says to inform them that you recently consumed the Diamond Shruumz-brand chocolate bars, cones and gummies.

LISTEN TO THE TOP FIVE HERE
Sponsored By One Nevada Credit Union
Don't miss the big stories. Like us on Facebook.
THE LATEST
Nevada’s dismal ranking on mental health unacceptable

I cringed when I saw Mental Health America’s recent assessment of Nevada based on prevalence of mental health conditions and limited access to services.

Why taking a daily multivitamin may backfire

If you’re taking a multivitamin to help you live longer, a new study by researchers at the National Cancer Institute may prompt you to reconsider.